You are here: Industry Insights > Dry Eye Disease

News List

Neuroptika Announces Enrollment of First Patient in Dry Eye Disease Trial americanpharmaceuticalreview
January 19, 2020
Neuroptika announced the first patient was enrolled in a Phase 2 clinical trial of NRO-1 for the treatment of dry eye disease. NRO-1 is a novel therapeutic with the potential to protect and regenerate corneal nerves in ophthalmic diseases.
Kala Receives CRL from FDA for KPI-121 0.25% NDA for Dry Eye Disease americanpharmaceuticalreview
August 12, 2019
Kala Pharmaceuticals has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s new drug application (NDA) for KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease.
Winter's Many Challenges to Eye Health drugs
December 24, 2018
Dry, itchy eyes are a common problem in the winter and low humidity is a major reason, one ophthalmologist says."On average, the humidity drops in the winter with the colder weather,"......
Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial fiercebiotech
September 28, 2018
Shares in Aldeyra rose more than 30% in premarket trading following the news.
Aldeyra Therapeutics Announces Positive Results from Dry Eye Disease Clinical Trial americanpharmaceuticalreview
September 27, 2018
Aldeyra Therapeutics announced positive results from its Phase 2b clinical trial of topical ocular reproxalap in patients with dry eye disease.
Aldeyra Therapeutics Announces First Patient Enrolled in Dry Eye Disease Phase 2b Clinical Trial biospace
January 31, 2018
Aldeyra Therapeutics, today announced that it has enrolled the first patient in a Phase 2b clinical trial of topical ocular reproxalap for the treatment of dry eye disease (DED).
Imprimis Pharmaceuticals Acquires License to Patented Ophthalmic Formulation for Dry Eye Disease americanpharmaceuticalreview
April 07, 2017
Imprimis Pharmaceuticals has entered into an licensing agreement for the exclusive worldwide rights to Klarity, an innovative and patented ophthalmic topical solution and gel technology for patients with dry eye disease (DED).

Previous page 1 2 Next page